Boothbay Fund Management, LLC Harrow Health, Inc. Transaction History

Boothbay Fund Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.75 - $7.74 $92,718 - $124,807	-16,125 Reduced 12.89%	108,929 $793,000
Q1 2022 May 16, 2022	SELL	$6.77 - $8.66 $36,388 - $46,547	-5,375 Reduced 4.12%	125,054 $853,000
Q4 2021 Feb 14, 2022	SELL	$8.5 - $12.0 $627,087 - $885,300	-73,775 Reduced 36.13%	130,429 $1.13 Million
Q3 2021 Nov 15, 2021	BUY	$6.99 - $10.6 $723,947 - $1.1 Million	103,569 Added 102.92%	204,204 $1.86 Million
Q2 2021 Aug 16, 2021	BUY	$6.68 - $11.07 $672,241 - $1.11 Million	100,635 New	100,635 $935,000
Q1 2021 May 17, 2021	SELL	$6.26 - $11.03 $221,917 - $391,013	-35,450 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$4.76 - $6.93 $82,019 - $119,410	-17,231 Reduced 32.71%	35,450 $243,000
Q3 2020 Nov 16, 2020	BUY	$4.71 - $7.36 $248,127 - $387,732	52,681 New	52,681 $294,000
Q1 2020 May 15, 2020	SELL	$3.5 - $7.31 $39,959 - $83,458	-11,417 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.6 - $7.88 $52,518 - $89,965	11,417 New	11,417 $89,000
Q3 2019 Nov 14, 2019	SELL	$4.89 - $8.0 $231,639 - $378,960	-47,370 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.2 - $8.7 $198,954 - $412,118	47,370 New	47,370 $412,000

177

21.4M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $992M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.